首页>
外国专利>
ULTRA-SMALL RNAS AS TOLL-LIKE RECEPTOR-3 ANTAGONISTS
ULTRA-SMALL RNAS AS TOLL-LIKE RECEPTOR-3 ANTAGONISTS
展开▼
机译:超小型RNAS作为TOLL-like RECEPTOR-3拮抗剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
Provided are methods and compositions for the treatment or prevention of macular degeneration or other diseases or disorders associated with activation of TLR3. Administration of double-stranded RNAs having a length of 22 nucleotides or less treats or prevents macular degeneration or other diseases or disorders associated with activation of TLR3 due to the ability of the RNAs to bind to but not activate TLR3. Furthermore, all double-stranded RNAs (both targeted and non- targeted) of 22 nucleotides or less in length can bind to but not activate TLR3 and thereby treat or prevent such conditions. Also provided is a method for increasing the specificity of a desired siRNA target knockdown, the method comprising administering an amount of a target siRNA sufficient to knockdown a target gene and an amount of a double stranded RNA of 22 nucleotides or less which prevents the target siRNA from activating TLR3.
展开▼